Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research


Apr 30, 2019

In this interview, Freek Verheugt and Colin Berry discuss T-TIME, a randomized, double blind, placebo-controlled, parallel group, multicenter clinical trial of low-dose adjunctive alteplase during primary percutaneous coronary intervention.